Main > NEUROLOGY. > Endothelin Receptor AntAgonists > ClazoSentan. > NonGeneric ClazoSentan



NonGeneric ClazoSentan's subsections
Clinical Status: Phase II (10.03)
Company:

NonGeneric ClazoSentan's products
This section has no products